Anti-Cytomegalovirus Therapy: Whether and When to Initiate, Those Are the Questions

Cytomegalovirus (CMV) reactivation in patients with autoimmune bullous disease (AIBD) or severe drug eruption treated with immunosuppressive therapy was traditionally thought to be merely an epiphenomenon of the underlying immunosuppression. However, a detailed review of the clinical course of these...

Descripción completa

Detalles Bibliográficos
Autores principales: Aoyama, Yumi, Sugiyama, Seiko, Yamamoto, Takenobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325238/
https://www.ncbi.nlm.nih.gov/pubmed/35890096
http://dx.doi.org/10.3390/ph15070797

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325238/
https://www.ncbi.nlm.nih.gov/pubmed/35890096
http://dx.doi.org/10.3390/ph15070797

Ejemplares similares